Cargando…
A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity
The selectivity of an enzyme inhibitor is a key determinant of its usefulness as a tool compound or its safety as a drug. Yet selectivity is never assessed comprehensively in the early stages of the drug discovery process, and only rarely even in the later stages, because technical limitations prohi...
Autores principales: | Bachovchin, Daniel A., Koblan, Luke W., Wu, Wengen, Liu, Yuxin, Li, Youhua, Zhao, Peng, Woznica, Iwona, Shu, Ying, Lai, Jack H., Poplawski, Sarah E., Kiritsy, Christopher P., Healey, Sarah E., DiMare, Matthew, Sanford, David G., Munford, Robert S., Bachovchin, William W., Golub, Todd R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953424/ https://www.ncbi.nlm.nih.gov/pubmed/24997602 http://dx.doi.org/10.1038/nchembio.1578 |
Ejemplares similares
-
Human FGF-21 Is a Substrate of Fibroblast Activation Protein
por: Coppage, Andrew L., et al.
Publicado: (2016) -
Substrate-Free High-Throughput Screening Identifies Selective Inhibitors for Uncharacterized Enzymes
por: Bachovchin, Daniel A., et al.
Publicado: (2009) -
Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice
por: Panaro, Brandon L., et al.
Publicado: (2018) -
Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation
por: Han, Ruijun, et al.
Publicado: (2015) -
The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)